Rosuvastatin 10 mg tablet.

DRUG2 trials

Sponsors

Advenchen Laboratories, LLC, Ain Shams University

Conditions

Alveolar Soft Part SarcomaLeiomyosarcomaMDDMajor Depressive DisorderSoft-Tissue SarcomaSynovial Sarcoma

Phase 3

Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)

RecruitingNCT03016819

Advenchen Laboratories, LLCAlveolar Soft Part Sarcoma, Leiomyosarcoma, Soft-Tissue Sarcoma +1

Start: 2017-08-15End: 2028-12-01Target: 325Updated: 2026-02-25

Efficacy of Statins Among Major Depressive Disorder

RecruitingNCT06698666

Ain Shams UniversityMajor Depressive Disorder, MDD

Start: 2022-10-01End: 2025-12-31Target: 145Updated: 2025-08-17

Related Papers

A randomized phase III trial of catequentinib hydrochloride (AL3818) versus placebo in subjects with metastatic or advanced leiomyosarcoma (LMS).

Journal of Clinical Oncology2025-05-281 citations

A phase III study (APROMISS) of AL3818 (Catequentinib, Anlotinib) hydrochloride monotherapy in subjects with metastatic or advanced synovial sarcoma.

Journal of Clinical Oncology2021-05-2025 citations